Boeckmann, Melanie http://orcid.org/0000-0001-5909-5508
Warsi, Sahil http://orcid.org/0000-0002-0600-4235
Noor, Maryam
Dogar, Omara
Mustagfira, Esha Haowa
Firoze, Fariza
Zahid, Raana
Readshaw, Anne
Siddiqi, Kamran
Kotz, Daniel http://orcid.org/0000-0002-9454-023X
Keding, Ada
Gabe, Rhian
Marshall, Anna
Parrott, Steve
Swami, Shilpi
Khan, Amina
Raja, Sonia
Sohail, Salman
Huque, Rumana
Barua, Deepa
Huque, Samina
Jahan, Iashrat
Fatima, Razia
Qadeer, Ejaz
Sheikh, Aziz
Elsey, Helen
Karki, Jiban
Králíková, Eva
Nohavova, Iveta
Zvolska, Kamila
Pankova, Alexandra
Baral, Sushil
Regmi, Shophika
Shrestha, Prabin
Khanal, Sudeepa
Joshi, Basant
,
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (680995, 680995, 680995, 680995, 680995, 680995, 680995, 680995, 680995)
Article History
Received: 17 January 2019
Accepted: 2 August 2019
First Online: 3 September 2019
Competing interests
: K.S. received a research grant from Pfizer (2015–2017) to study the effect of varenicline (a smoking cessation medicine) on waterpipe smoking cessation. D.K. received an unrestricted grant from Pfizer in 2009 for an investigator-initiated trial on the effectiveness of practice nurse counselling and varenicline for smoking cessation in primary care (Dutch Trial Register NTR3067; ExternalRef removed). The other authors declare no competing interests. Aflofarm Pharma Poland provided cytisine and placebo free of cost for the trial; however, they have no role in the trial conduct, its analysis or dissemination of results nor in any aspects of the implementation study component.